US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eikon Therapeutics

8.62

-0.8700-9.17%

Volume:398.56K

Turnover:3.56M

Market Cap:465.34M

PE:-1.45

High:9.64

Open:9.47

Low:8.51

Close:9.49

52wk High:17.40

52wk Low:7.90

Shares:53.98M

Float Shares:17.65M

Volume Ratio:0.81

T/O Rate:2.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.9500

EPS(LYR):-115.2900

ROE:-125.02%

ROA:-36.19%

PB:1.00

PE(LYR):-0.07

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Major Investor Makes Bold Move on Eikon Therapeutics Shares

Column Group IV GP Reports Purchase of 89,200 Eikon Therapeutics Shares Valued at $1.03 Million

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Eikon Therapeutics Appoints Ching-Pin Chang, M.d., Ph.d. as Executive Vice President and Chief Scientific Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/EIKN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EIKN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","market":"US","secType":"STK","nameCN":"Eikon Therapeutics","latestPrice":8.62,"timestamp":1789579801993,"preClose":9.49,"halted":0,"volume":398556,"delay":0,"changeRate":-0.0916754478398315,"floatShares":17648000,"shares":53984300,"eps":-5.95,"marketStatus":"Trading","change":-0.87,"latestTime":"09-16 13:30:03 EDT","open":9.47,"high":9.6388,"low":8.51,"amount":3563104.9880159996,"amplitude":0.118946,"askPrice":8.64,"askSize":122,"bidPrice":8.6,"bidSize":225,"shortable":0,"etf":0,"ttmEps":-5.95,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"listingDate":1770267600000,"exchange":"NASDAQ","adjPreClose":9.49,"preHourTrading":{"tag":"盘前","latestPrice":8.9803,"preClose":9.49,"latestTime":"09:21 EDT","volume":212,"amount":1907.6258199999997,"timestamp":1789564862408,"change":-0.5097,"changeRate":-0.053709,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":9.36,"preClose":9.49,"latestTime":"19:30 EDT","volume":5600,"amount":52974.03,"timestamp":1789515007602,"change":-0.13,"changeRate":-0.013699,"amplitude":0.028451},"volumeRatio":0.809383},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","floatShares":17648000,"roa":"-36.19%","roe":"-125.02%","lyrEps":-115.29,"volumeRatio":0.809383,"shares":53984300,"dividePrice":0,"high":9.6388,"amplitude":0.118946,"preClose":9.49,"low":8.51,"week52Low":7.9,"pbRate":"1.00","week52High":17.4,"institutionHeld":0,"latestPrice":8.62,"committee":0.29683,"eps":-5.95,"divideRate":0,"volume":398556,"delay":0,"ttmEps":-5.95,"open":9.47,"prevYearClose":18,"prevWeekClose":8.94,"prevMonthClose":10.46,"prevQuarterClose":13.05,"fiveDayClose":10.73,"twentyDayClose":11.65,"sixtyDayClose":9.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EIKN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"EIKN","fiscalQuarterEnding":"2026/06","expectedEps":-1.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.63},{"market":"US","date":"2026-05-11","symbol":"EIKN","fiscalQuarterEnding":"2026/03","expectedEps":-1.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-2.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EIKN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EIKN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0,"sell":0,"strongSell":0.1667,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1774929600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EIKN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EIKN","date":"2026-09-15","current":-1.448739,"percent":0.728477,"low":-3.139466,"twenty":-2.079722,"median":-1.759483,"eighty":-1.536491,"high":-1.335246,"avg":-1.854921,"sd":0.37496,"marketCap":506984680},"quantilePoints":[{"date":"2026-02-06","current":-2.616222,"twenty":-3.034817,"median":-2.877844,"eighty":-2.720871,"marketCap":809765055},{"date":"2026-02-13","current":-2.586571,"twenty":-2.610292,"median":-2.537735,"eighty":-2.527619,"marketCap":800587717},{"date":"2026-02-20","current":-2.703429,"twenty":-2.7418,"median":-2.616222,"eighty":-2.529014,"marketCap":836757223},{"date":"2026-02-27","current":-2.379017,"twenty":-2.703429,"median":-2.596164,"eighty":-2.52727,"marketCap":736346356},{"date":"2026-03-06","current":-2.535991,"twenty":-2.644128,"median":-2.595292,"eighty":-2.523782,"marketCap":784932259},{"date":"2026-03-13","current":-2.054606,"twenty":-2.624942,"median":-2.562153,"eighty":-2.406924,"marketCap":635935489},{"date":"2026-03-20","current":-1.915074,"twenty":-2.616222,"median":-2.529014,"eighty":-2.298787,"marketCap":592748020},{"date":"2026-03-27","current":-1.836588,"twenty":-2.600524,"median":-2.515933,"eighty":-2.054606,"marketCap":568455068},{"date":"2026-04-02","current":-1.678228,"twenty":-2.599129,"median":-2.426109,"eighty":-1.985189,"marketCap":544162116},{"date":"2026-04-10","current":-1.504368,"twenty":-2.597385,"median":-2.379017,"eighty":-1.821565,"marketCap":487788380},{"date":"2026-04-17","current":-1.876704,"twenty":-2.595641,"median":-2.269137,"eighty":-1.751381,"marketCap":608517358},{"date":"2026-04-24","current":-1.786542,"twenty":-2.595292,"median":-2.061583,"eighty":-1.769507,"marketCap":579282538},{"date":"2026-05-01","current":-1.605383,"twenty":-2.588315,"median":-2.045013,"eighty":-1.651966,"marketCap":520542206},{"date":"2026-05-08","current":-1.531083,"twenty":-2.547502,"median":-1.986901,"eighty":-1.641614,"marketCap":496450549},{"date":"2026-05-15","current":-2.105086,"twenty":-2.53634,"median":-1.963159,"eighty":-1.651966,"marketCap":713546154},{"date":"2026-05-22","current":-1.782455,"twenty":-2.530409,"median":-1.936811,"eighty":-1.659647,"marketCap":604186273},{"date":"2026-05-29","current":-1.645097,"twenty":-2.527968,"median":-1.929027,"eighty":-1.650964,"marketCap":557627116},{"date":"2026-06-05","current":-1.562046,"twenty":-2.525177,"median":-1.895889,"eighty":-1.633553,"marketCap":529475781},{"date":"2026-06-12","current":-1.360801,"twenty":-2.514363,"median":-1.841551,"eighty":-1.597703,"marketCap":461261110},{"date":"2026-06-18","current":-1.55406,"twenty":-2.482968,"median":-1.809917,"eighty":-1.567693,"marketCap":526768850},{"date":"2026-06-26","current":-1.573226,"twenty":-2.429947,"median":-1.776985,"eighty":-1.53713,"marketCap":533265485},{"date":"2026-07-02","current":-1.95655,"twenty":-2.406226,"median":-1.79823,"eighty":-1.541282,"marketCap":663198193},{"date":"2026-07-10","current":-1.79204,"twenty":-2.398552,"median":-1.809917,"eighty":-1.555657,"marketCap":607435406},{"date":"2026-07-17","current":-1.589198,"twenty":-2.377273,"median":-1.784498,"eighty":-1.563963,"marketCap":538679348},{"date":"2026-07-24","current":-1.536491,"twenty":-2.355995,"median":-1.761474,"eighty":-1.543838,"marketCap":520813601},{"date":"2026-07-31","current":-1.536491,"twenty":-2.298787,"median":-1.731347,"eighty":-1.536491,"marketCap":520813601},{"date":"2026-08-07","current":-1.471006,"twenty":-2.239486,"median":-1.715581,"eighty":-1.534894,"marketCap":498616763},{"date":"2026-08-14","current":-1.736786,"twenty":-2.116266,"median":-1.712181,"eighty":-1.534894,"marketCap":559524759},{"date":"2026-08-21","current":-1.807401,"twenty":-2.105086,"median":-1.719889,"eighty":-1.534894,"marketCap":582274072},{"date":"2026-08-28","current":-1.936861,"twenty":-2.105086,"median":-1.736786,"eighty":-1.536491,"marketCap":623981145},{"date":"2026-09-04","current":-1.842708,"twenty":-2.084325,"median":-1.759483,"eighty":-1.536491,"marketCap":593648728},{"date":"2026-09-11","current":-1.54848,"twenty":-2.084271,"median":-1.760899,"eighty":-1.536491,"marketCap":498859926},{"date":"2026-09-15","current":-1.5737,"twenty":-2.079722,"median":-1.759483,"eighty":-1.536491,"marketCap":506984680}],"updateTime":1789579803888},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EIKN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666730998","title":"Major Investor Makes Bold Move on Eikon Therapeutics Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666730998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666730998?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:06","pubTimestamp":1788919582,"startTime":"0","endTime":"0","summary":"New insider activity at Eikon Therapeutics, Inc. ( ($EIKN) ) has taken place on September 8, 2026. Significant shareholder Column Group GP IV LP ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-on-eikon-therapeutics-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-on-eikon-therapeutics-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EIKN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666637712","title":"Column Group IV GP Reports Purchase of 89,200 Eikon Therapeutics Shares Valued at $1.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666637712","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666637712?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:34","pubTimestamp":1788899655,"startTime":"0","endTime":"0","summary":"Column Group IV GP reports purchase of 89,200 Eikon Therapeutics shares valued at $1.03 millionColumn Group IV GP reported a purchase of 89,200 Eikon Therapeutics common shares at USD 11.56.Indirect holdings reported at 4,312,139 shares via Column Group IV, 1,319,164 via Column Group Opportunity III, 148,840 via Column Group IV-A.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9sNLXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Column Group IV GP Reports Purchase of 89,200 Eikon Therapeutics Shares Valued at $1.03 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIKN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487978","title":"Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487978","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487978?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:32","pubTimestamp":1788435147,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics names Ching-Pin Chang as chief scientific officerEikon Therapeutics named Ching-Pin “CP” Chang executive vice president, chief scientific officer.Chang joins from Bristol Myers Squi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9l9Cns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU2087621335.USD","IHE","BIB","LU1718418525.SGD","BMED","LU1839511570.USD","LU0859254822.USD","BBH","LU0122379950.USD","IBB","LU1236620834.HKD","LU0965509010.AUD","IE00BKPKM429.USD","LU1983299246.USD","LU1093756168.USD","LU1093756325.SGD","LU1057294990.SGD","LU2360032135.SGD","LU0321505868.SGD","LU1934455194.USD","LU2125154778.USD","IE00B64PRP62.GBP","LU0267386448.USD","IBBQ","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2242652126.USD","GILD","NDAQ","LU2133065610.SGD","LU0306807586.USD","MEDI","LU2242646821.SGD","LU2095319765.USD","SG9999014021.USD","LU0109394709.USD","BMY","LU1585245621.USD","TBXU","BCDF","BK4550","EIKN","LU1291159041.SGD","TMED","LU1023059063.AUD","BK4585","IE00BQXX3C00.GBP","LU2089984988.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887923","title":"Eikon Therapeutics Appoints Ching-Pin Chang, M.d., Ph.d. as Executive Vice President and Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887923","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887923?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:30","pubTimestamp":1788435001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA3N4SRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EIKN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EIKN\",params:#limit:6,delay:false,,,undefined,":[]}}